Par’s Megace Extra Strength May Launch With Contract Sales Force
This article was originally published in The Pink Sheet Daily
Executive Summary
The company will likely seek an exclusive sales force of 40 to 80 reps for the reformulated version of Bristol’s megestrol oral suspension product. Par expects to launch in mid-2005; its 505(b)(2) NDA has a user fee date of April 29.